• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway

    2016-12-02 02:30:12QingrongLiZhuoWangWeiZhouShouruiFanRunMaLiXueLuYangYashanLiHongliTanQinghuaShaoHongyingYang

    Qing-rong Li, Zhuo Wang, Wei Zhou, Shou-rui Fan, Run Ma, Li Xue, Lu Yang, Ya-shan Li, Hong-li Tan, Qing-hua Shao, Hong-ying Yang,

    1 Second Affiliated Hospital of Kunming Medical University, Department of Clinical Laboratory, Kunming, Yunnan Province, China

    2 Third People’s Hospital of Yunnan Province, Kunming, Yunnan Province, China

    RESEARCH

    Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway

    Qing-rong Li1, Zhuo Wang1, Wei Zhou2, Shou-rui Fan1, Run Ma1, Li Xue1, Lu Yang1, Ya-shan Li2, Hong-li Tan2, Qing-hua Shao2, Hong-ying Yang1,*

    1 Second Affiliated Hospital of Kunming Medical University, Department of Clinical Laboratory, Kunming, Yunnan Province, China

    2 Third People’s Hospital of Yunnan Province, Kunming, Yunnan Province, China

    Graphical Abstract

    orcid: 0000-0001-6740-880X (Hong-ying Yang)

    Epalrestat is a noncompetitive and reversible aldose reductase inhibitor used for the treatment of diabetic neuropathy. This study assumed that epalrestat had a protective effect on diabetic peripheral nerve injury by suppressing the expression of aldose reductase in peripheral nerves of diabetes mellitus rats. The high-fat and high-carbohydrate model rats were established by intraperitoneal injection of streptozotocin. Peripheral neuropathy occurred in these rats after sustaining high blood glucose for 8 weeks. At 12 weeks after streptozotocin injection, rats were intragastrically administered epalrestat 100 mg/kg daily for 6 weeks. Transmission electron microscope revealed that the injuries to myelinated nerve fibers, non-myelinated nerve fibers and Schwann cells of rat sciatic nerves had reduced compared to rats without epalrestat administuation. Western blot assay and immunohistochemical results demonstrated that after intervention with epalrestat, the activities of antioxidant enzymes such as superoxide dismutase, catalase and glutathione peroxidase gradually increased, but aldose reductase protein expression gradually diminished. Results confirmed that epalrestat could protect against diabetic peripheral neuropathy by relieving oxidative stress and suppressing the polyol pathway.

    nerve regeneration; peripheral nerve injury; streptozotocin; reactive oxygen species; diabetic neuropathy; oxidative stress; aldose reductase; antioxidant enzymes; polyol pathway; aldose reductase inhibitor; superoxide dismutase; catalase; glutathione peroxidase; rats; NSFC grant; neural regeneration

    Introduction

    As one of the most common complications of diabetes mellitus (DM), diabetic peripheral neuropathy (DPN) has long been a topic of research (Obrosova, 2009). Up-regulation of the polyol and hexosamine pathways and increases in the levels of non-enzymatic glycation products and activity of protein kinase C are responsible for the occurrence of diabetic complications (Brownlee, 2005). However, inhibition of those pathways and enzymes has not provided the expected outcomes. Banting laureate, Prof. Brownlee, recently proposed the theory that excess reactive oxygen species in the mitochondria is the major cause of diabetic complications (Brownlee, 2005).

    Oxidative stress is manifested as a series of reactions initiated by an imbalance between oxidative substances and antioxidant capacity, which is accompanied by an increase in reactive oxygen species production and impaired antioxidative defenses(Singh et al., 2014). Oxidative stress is widely accepted as a key mediator in the development and progression of diabetic complications (Babizhayev et al., 2014). Clarifying the changes in the concentrations, activities and distribution of antioxidant defenses during diabetic peripheral neuropathy is important to direct therapy (Vincent et al., 2013). Diabetic hyperglycemia can activate the polyol pathway (Tarr et al., 2013), which converts glucose into sorbitol by the rate-limiting enzyme, aldose reductase. Sorbitol can be converted into fructose via fructose reductase (Obrosova, 2009) but the absence of fructose kinase in peripheral nervous tissue results in the accumulation of sorbitol causing intracellular hypertonia and inhibits inositol uptake (Schemmel et al., 2010). Intracellular inositol becomes exhausted, resulting in edema, demyelination and necrosis of peripheral nerves (Polak et al., 2013).

    The aim of the current study was to evaluate the effects of epalrestat, an aldose reductase inhibitor (ARI), on oxidative stress and changes in aldose reductase in streptozotocin-induced DM. It was proposed that epalrestat could prevent peripheral nerve injury through inhibition of antioxidant enzymes and aldose reductase expressions in the peripheral nerves of rats. Subsequent analysis would add to an objective evaluation of diabetic peripheral neuropathy.

    Materials and Methods

    Animals

    Seventy-six 8-week-old male Sprague-Dawley rats weighing 170-190 g were purchased from the Laboratory Animal Center of Kunming Medical University of China (license No. SYXK (Dian) K2015-0002). The rats were housed in cages for at least 1 week for choosing healthy rats.

    The investigation conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication No. 85-23, revised in 1996). Animal experiments followed the ethical standards approved by the Research Ethics Committee of Kunming Medical University of China.

    In the first week, the rats were randomly divided into a control group (n = 30) and a DM group (n = 46). Rats in the DM group were treated with high-fat and high-sugar diet for 4 weeks, and injected with streptozotocin at 4 and 8 weeks. Twelve weeks later, the above two groups were divided into four groups: non-diabetes mellitus (nDM) (ARI-) group (n = 15; nDM rats without epalrestat administration), nDM (ARI+) group (n = 15; nDM rats with epalrestat administration), DPN (ARI-) group (n = 20; DPN rats without epalrestat administration), and DPN (ARI+) group (n = 26; DPN rats with epalrestat administration).

    Establishment of DPN models and drug administration

    The DM group consisted of 46 rats that were treated with highfat and high-sugar diet for 4 weeks. Food composition was 32% carbohydrate, 28% fat, 17% protein and 23% other to induce insulin resistance. The rats were intraperitoneally injected twice with streptozotocin dissolved in citric acid-sodium citrate buffer (Sigma-Aldrich, St. Louis, MO, USA). The first injection (25 mg/kg body weight) was conducted after 4 weeks and the second injection (40 mg/kg body weight) was conducted after 8 weeks on the diet (Islam and Choi, 2007). Blood glucose was obtained by repeated needle puncture of the tail tip veins to determine hyperglycemia. Blood glucose concentrations were determined using Bayer Glucometer Elite? and compatible blood glucose test strips (Bayer, Pittsburgh, PA, USA). Rats with a blood glucose level > 16 mM were considered DM group and those with blood glucose level < 16 mM were considered non-diabetic group (Chen et al., 2015).

    Twelve weeks after the streptozotocin induction, all rats underwent an electrophysiological examination to check that the rats suffered from DPN. Blood samples were obtained by repeated needle puncture of the tail tip veins (Jin et al., 2012) to measure serum insulin, glycated hemoglobin and cholesterol levels to check whether insulin resistance had occurred. Serum insulin was determined with an electrochemical immunoassay. The equation for serum insulin resistance was the fasting blood glucose × fasting serum insulin/22.5. The glycated hemoglobin and cholesterol levels were measured (Olympus 5421 instrument, Olympus Corporation, Tokyo, Japan). The nDM (ARI+) group and DPN (ARI+) group (after they exhibited DNP) were fed with an ARI, epalrestat, by gavage (100 mg/kg/d) intraperitoneally for 6 weeks. After 6 weeks of ARI treatment, all rats were killed, and the sciatic nerves were rapidly removed from the right legs and placed in a freezing tube.

    Serum total cholesterol, triglyceride, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol

    Blood samples were collected from the femoral artery of rats at week 12 following streptozotocin injection and were transferred to sterilized centrifuge tubes (Pedchenko and Malakhov, 1991). The samples were centrifuged at 4,000 × g for 5 minutes to obtain the serum and stored in a freezer for later analysis of total cholesterol, triglyceride, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol. They were measured by an enzymatic method of the automatic biochemical analyzer (Rainwater et al., 1995).

    Neurophysiological examination

    At 12 weeks after the second streptozotocin injection, streptozotocin-induced and control rats were anesthetized with 10% chloral hydrate (300 mg/kg body weight) and neuropathy measured with an electric stimulator (SDZ-V, Suzhou Medical Instrument Co., Ltd., Suzhou, China) and muscle power amplifier (AD Instruments, Sydney, Australia) (Zhang et al., 2008). The right sciatic nerve was stimulated proximally at the level of the sciatic notch and distal right side of the foot with an input electrode. A reference electrode was located in the rat’s tail. The rats were treated with an electrical stimulation signal with a pulse width of 0.1 ms and stimulation intensity 1.5 times the threshold. The body temperature was automatically maintained at a mean rectal temperature of 37.5-37.9°C. The computer recorded the time of the action potentials, respectively, from the stimulated nerves to the distal muscle. We repeated electrical stimulation three times, each with a time interval of 1 minute, and took the average value.

    Transmission electron microscope observations

    The rats were killed at 6 weeks of ARI treatment. The sciatic nerves of DM rats were excised and subdivided into small samples for transmission electron microscopy (JEM-1011, JEOL, Tokyo, Japan). The sciatic nerves of DM rats were rinsed three times with cacodylate buffer, fixed in 1% osmium tetroxide for 2 hours at room temperature, rinsed with cacodylate buffer three times again, and placed in buffer overnight. The samples were then dehydrated in 30%, 50%, 70%, 90% alchohol and 70% acetone, embedded in resin, cut into small sections, and stained with 2% uranyl acetate for 30 minutes, rinsed with distilled water, stained with 2% uranyl acetate for 30 minutes, rinsed with distilled water and lead citrate for an additional 30 minutes and rinsed with distilled water. The above samples were examined with an accelerating voltage of 80 kV.

    Protein expression measured by western blot assay

    Sciatic nerve proteins from each group were separated on 12% polyacrylamide gels and transferred to a polyvinylidene difluoride membrane. These membranes were incubated for 2 hours at room temperature in 3% bovine serum albumin. The primary polyclonal antibodies were rabbit anti-rat aldose reductase (37 kDa), glutathione peroxidase 1 (GPX, 22 kDa), superoxide dismutase (SOD, 18 kDa), catalase (CAT, 60 kDa) (1:1,000, 1:5,000, 1:1,000, 1:2,000; Abcam, Cambridge, MA,USA). The membranes were incubated with primary antibodies overnight at 4°C and with secondary antibody (goat anti-rabbit IgG, monoclonal antibody; 1:15,000; Zhongshan Golden Bridge Biotechnology Co., Ltd., Beijing, China) over 2 hours at room temperature. After three washes in Tris-buffered saline with Tween, immunoreactive complexes were visualized using an enhanced chemiluminescence system (Bio-Rad, Hercules, CA,

    USA). β-Actin served as an internal positive control.

    Immunohistochemistry

    Samples were fixed in 4% paraformaldehyde, dehydrated in ascending alcohols and embedded in paraffin. Serial sections were cut from a paraffin block. The following primary antibodies were used: rabbit anti-rat aldose reductase (37 kDa), GPX (22 kDa), SOD superoxide dismutase (18 kDa), catalase (60 kDa; 1:1,000, 1:5,000, 1:1,000, 1:2,000; Abcam). The sections were incubated with primary antibody overnight at 4° C, and then incubated with goat anti-rabbit secondary antibody (1:15,000; Zhongshan Golden Bridge Biotechnology) for 2 hours at room temperature. The reactions were visualized using 3,3′-diaminobenzidine reagent (Boster Biological Tech-nology Ltd., Wuhan, Hubei Province, China). Nuclei were counterstained with hematoxylin. The sections were examined under a light microscope (Olympus, Tokyo, Japan).

    Table 1 Basic profile of rats in the diabetes mellitus group (week 12 following model establishment) and control group

    Figure 1 Effects of epalrestat, an ARI, on the ultrastructure of sciatic nerve cells in DM rats.

    Figure 2 Effects of epalrestat, an ARI, on SOD activity in sciatic nerve of DM rats.

    Figure 3 Effects of epalrestat, an ARI, on CAT activity in sciatic nerve of DM rats.

    Statistical analysis

    Statistical analyses were performed using SPSS 17.0 software (SPSS, Chicago, IL, USA). Data are expressed as the mean ± SEM. One-way analysis of variance and the least significant difference post hoc test were used among groups. P < 0.05 was considered statistically significant.

    Figure 4 Effects of epalrestat, an ARI, on GPX activity in sciatic nerve of DM rats.

    Figure 5 Effects of epalrestat, an ARI, on AR activity in sciatic nerve of DM rats.

    Results

    Effects of epalrestat on serological indexes of DPN rats

    Blood samples were collected at week 12 following streptozotocin injection in the control group and DM group. Blood glucose, low-density lipoprotein cholesterol, triglyceride, total cholesterol and glycated hemoglobin levels were elevated at week 12 following streptozotocin injection (P < 0.05, P < 0.01), whereas body weights of the DM group were lower than controls (Table 1), but the high-density lipoprotein cholesterol level was not significantly different from the control group.

    Effects of epalrestat on sciatic nerve function of DPN ratsSciatic nerve conduction latency was slower in the DM group (1.47 ± 0.10 ms) than in the control group (1.13 ± 0.07 ms) (P < 0.01).

    Effects of epalrestat on ultrastructure of cells of sciatic nerve of DPN rats

    To study the neural cell changes in each group, the sciatic nerves were analyzed using electron microscopy. In the DPN (ARI-) group, myelin sheath cells became disordered in the medullated fibers of sciatic nerves. Shrinkage, deformation and inhomogeneity were observed in neurites. The structures of Schwann cells blurred and the vacuoles degenerated, but the integrity of cell membranes was not lost. Cells of non-myelinated nerves swelled, with irregular morphology and widened cellular spaces. Schwann cells shrank (Figure 1C). In the DPN (ARI+) group, the pathological structures of neurites and myelin were significantly improved. Deranged myelin sheath cells recovered and Schwann cell swelling was attenuated (Figure 1D).

    SOD, CAT, GPX and aldose reductase expression in the streptozotocin-induced DPN rats and ARI-treated DPN rats

    To confirm the SOD, CAT and GPX changes of ARI-treated DPN rats, western blot assay and immunohistochemistry were used to detect the protein levels at week 16 following streptozotocin induction. As illustrated in Figures 2-4, SOD, CAT and GPX protein levels were lower in the DPN (ARI-) group than in the nDM (ARI-) group. SOD, CAT and GPX protein levels were higher in the DPN (ARI+) group compared with the DPN (ARI-) group (P < 0.05). No significant differences in SOD, CAT and GPX protein levels were detected between the nDM (ARI-) and nDM (ARI+) groups (P > 0.05) (Figures 2A, 2B, 3A, 3B, 4A, 4B). Immunohistochemical results show that the SOD-, CAT-, and GPX-positive signals were mainly expressed in the cytoplasm and cell membranes, particularly in Schwann cell nuclei, Schwann cytoplasm, and myelin sheath in the DPN (ARI-) group (Figures 2C, 3C, 4C).

    In DPN rats, the protein levels of aldose reductase significantly increased in sciatic nerves of DM rats in the DPN (ARI-) group (P < 0.05). There was a decrease in aldose reductase of the DPN (ARI+) group (P < 0.05). There was no significant difference in protein levels of aldose reductase between the nDM (ARI-) and nDM (ARI+) groups (P > 0.05; Figure 5A, B). Consistent with these observations, aldose reductase immunostaining revealed an accumulation of the aldose reductase protein in Schwann cells of sciatic nerve, while aldose reductase expression was low in the myelin sheath and axons in the DPN (ARI-) group (Figure 5C).

    Discussion

    In the present study, no significant difference in SOD activity was detected between the nDM (ARI-) and nDM (ARI+) groups. With the progression of DM, SOD protein expression levels reduced gradually, and oxidative stress damage aggravated, which led to DPN. After intragastric administration of epalrestat, SOD protein expression levels increased. Currently, it is believed that the decreased SOD concentration in various body tissues reduced the active oxygen radical scavenging ability. This in turn may function as a direct damaging factor in parenchymal cells and the mesenchyme, thereby leading to structural and functional damages in related tissues (Cui et al., 2008). Results from this study demonstrated that no apparent different CAT expression was found between the nDM (ARI-) and nDM (ARI+) groups. As the course of diabetes progressed to the DPN stage, CAT protein expression decreased and oxidative stress aggravated, contributing to DPN. Moreover, the protein expression levels of CAT increased with intragastric administration of epalrestat. There are studies, however, reporting that changes in CAT activity were quite distinct from the expected results (Babizhayev et al., 2014), with some reduced, some increased, or some unchanged significantly, which may result from different rat species, ages or disease durations (Yang et al., 2013). That finding suggested alternative reimbursement mechanisms for the enhancement of anti-oxidative stress. The findings in the present study revealed no evident difference in GPX expression between the nDM (ARI-) and nDM (ARI+) groups. As the course of diabetes progressed to the DPN stage, GPX protein expression levels reduced gradually and oxidative stress aggravated, resulting in DPN. Intragastric administration of epalrestat increased the protein expression level of GPX.

    With the progression of DM, aldose reductase protein expression was gradually increased and oxidative stress aggravated, and resulting in DPN. However, the increase in aldose reductase protein expression was not quite significant. Subsequent intragastric epalrestat administration reduced the level of aldose reductase protein expression. Clinically the efficacy of ARIs is confirmed in attenuating peripheral neuropathy (Schemmel et al., 2010). However, the exact mechanisms and targets of ARIs have not been elucidated despite several reported studies (Obrosova et al., 2007). The exact role of ARIs is still an active topic in diabetes research (Colciago et al., 2002).

    The present study focuses on biomarkers, including SOD, catalase, GPX and aldose reductase, which are closely related to DPN. By recording changes in the biomarkers after ARI therapy, the influence of ARIs on the biomarkers can be determined (Gabbay, 2004). Changes in the biomarkers for the occurrence of diabetic complications can provide evidence for specifying whether a certain biomarker is predictive of diabetic peripheral neuropathy (Huang et al., 1999). Damage caused by oxidative stress in type II DM is now universally recognized (Liu et al., 2013). Accordingly, antioxidant therapy is applied in clinics all over the world (Russo, 2010). However, very few studies have explored the best time for intervention with an antioxidant therapy (Kalekar et al., 2013). No reliable marker has yet been recognized as an indicator of the recovery of the balance between oxidants and antioxidants. It has been proposed that by analyzing the changes in the DPN biomarkers, the key target of ARI could be specified (Hosseini and Abdollahi, 2013). The effective biomarkers identified could be used as indicators in laboratory examinations for evaluating drug efficacy and nerve damage.

    The results of the present study support other reports that antioxidase expression is decreased when DPN occurs (Kawai et al., 2010). As the disorder progresses, further decrease in antioxidase exacerbates reactive oxygen species damage (Yagi-hashi et al., 2001). Western blot assay and immunohistochemistry both indicated that SOD, CAT and GPX changed in the same direction, but aldose reductase changed in the opposite way. Aldose reductase was activated in DPN, but decreased after ARI administration. Aldose reductase, oxidative stress and subsequent metabolism, pathological and pathophysiological reactions jointly contributed to the occurrence and progression of DPN. This established the relationship of DM metabolic disorder as follows: aldose reductase activation - oxidative stress - vascular and nervous pathological changes - DPN. In summary, the present study provides experimental basis for how ARIs act to reduce DPN, reported elsewhere (Kawai et al., 2010). As a selective polyol pathway blocker, ARI can exclusively inhibit aldose reductase and reduce sorbitol accumulation in erythrocytes of DM patients and sorbitol and fructose accumulation in nervous tissues (Sullivan and Feldman, 2005). ARI can up-regulate the nitric oxide production of endothelial cells by inhibiting protein kinase pathways and down-regulate the expression of hyperglycemia-mediated neutrophil-endothelial adhesions and endothelial adhesions. Consequently, ARI can attenuate DPN.

    Author contributions: WZ provided technical assistance. ZW designed the study. QRL, HLT, HYY and SRF performed experiments. RM, LX and LY analyzed data. YSL and QHS wrote the paper. All authors approved the final version of the paper.

    Conflicts of interest: None declared.

    Plagiarism check: This paper was screened twice using Cross-Check to verify originality before publication.

    Peer review: This paper was double-blinded and stringently reviewed by international expert reviewers.

    Babizhayev MA, Strokov IA, Nosikov VV, Savel’yeva EL, Sitnikov VF, Yegor EY, Lankin VZ (2014) The role of oxidative stress in diabetic neuropathy: generation of free radical species in the glycation reaction and gene polymorphisms encoding antioxidant enzymes to genetic susceptibility to diabetic neuropathy in population of type i diabetic patients. Cell Biochem Biophys 71:1425-1443.

    Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625.

    Chen K, Xu J, He H, Zhao L, Xiong J, Mo Z (2015) Protective effect of silibinin on islet beta cells in C57BL/6J mice fed a highfat diet. Zhong Nan Da Xue Xue Bao Yi Xue Ban 40:165-170.

    Colciago A, Negri-Cesi P, Celotti F (2002) Pathogenesis of diabetic neuropathy--do hyperglycemia and aldose reductase inhibitors affect neuroactive steroid formation in the rat sciatic nerves? Exp Clin Endocrinol Diabetes 110:22-26.

    Cui XP, Li BY, Gao HQ, Wei N, Wang WL, Lu M (2008) Effects of grape seed proanthocyanidin extracts on peripheral nerves in streptozocin-induced diabetic rats. J Nutr Sci Vitaminol (Tokyo) 54:321-328.

    Gabbay KH (2004) Aldose reductase inhibition in the treatment of diabetic neuropathy: where are we in 2004? Curr Diab Rep 4:405-408.

    Hosseini A, Abdollahi M (2013) Diabetic neuropathy and oxidative stress: therapeutic perspectives. Oxid Med Cell Longev 2013:168039.

    Huang WC, Juang SW, Liu IM, Chi TC, Cheng JT (1999) Changes of superoxide dismutase gene expression and activity in the brain of streptozotocin-induced diabetic rats. Neurosci Lett 275:25-28.

    Islam MS, Choi H (2007) Nongenetic model of type 2 diabetes: a comparative study. Pharmacology 79:243-249.

    Jin HY, Lee KA, Song SK, Liu WJ, Choi JH, Song CH, Baek HS, Park TS (2012) Sulodexide prevents peripheral nerve damage in streptozotocin induced diabetic rats. Eur J Pharmacol 674:217-226.

    Kalekar SA, Munshi RP, Thatte UM (2013) Do plants mediate their anti-diabetic effects through anti-oxidant and anti-apoptotic actions? an in vitro assay of 3 Indian medicinal plants. BMC Complement Altern Med 13:257.

    Kawai T, Takei I, Tokui M, Funae O, Miyamoto K, Tabata M, Hirata T, Saruta T, Shimada A, Itoh H (2010) Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(varepsilon)-carboxymethyl lysine. J Diabetes Complications 24:424-432.

    Liu JF, Liu YH, Chen CM, Chang WH, Chen CY (2013) The effect of almonds on inflammation and oxidative stress in Chinese patients with type 2 diabetes mellitus: a randomized crossover controlled feeding trial. Eur J Nutr 52:927-935.

    Obrosova IG (2009) Diabetes and the peripheral nerve. Biochim Biophys Acta 1792:931-940.

    Obrosova IG, Ilnytska O, Lyzogubov VV, Pavlov IA, Mashtalir N, Nadler JL, Drel VR (2007) High-fat diet induced neuropathy of pre-diabetes and obesity: effects of “healthy” diet and aldose reductase inhibition. Diabetes 56:2598-2608.

    Pedchenko VV, Malakhov VN (1991) Enzymatic methods for quantitative determination of total cholesterol in blood serum. Vopr Med Khim 37:85-91.

    Polak G, Wertel I, Kwasniewski W, Derewianka-Polak M, Kotarski J (2013) The role of iron metabolism and oxidative stress in the pathogenesis of endometriosis. Ginekol Pol 84:62-64.

    Rainwater DL, Ludwig MJ, Haffner SM, VandeBerg JL (1995) Lipid and lipoprotein factors associated with variation in Lp(a) density. Arterioscler Thromb Vasc Biol 15:313-319.

    Russo AJ (2010) Increased serum Cu/Zn SOD in individuals with clinical depression normalizes after zinc and anti-oxidant therapy. Nutr Metab Insights 3:37-42.

    Schemmel KE, Padiyara RS, D’Souza JJ (2010) Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review. J Diabetes Complications 24:354-360.

    Singh R, Kishore L, Kaur N (2014) Diabetic peripheral neuropathy: current perspective and future directions. Pharmacol Res 80:21-35.

    Sullivan KA, Feldman EL (2005) New developments in diabetic neuropathy. Curr Opin Neurol 18:586-590.

    Tarr JM, Kaul K, Chopra M, Kohner EM, Chibber R (2013) Pathophysiology of diabetic retinopathy. ISRN Ophthalmol 2013:343560.

    Vincent AM, Calabek B, Roberts L, Feldman EL (2013) Biology of diabetic neuropathy. Handb Clin Neurol 115:591-606.

    Yagihashi S, Yamagishi SI, Wada Ri R, Baba M, Hohman TC, Yabe-Nishimura C, Kokai Y (2001) Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor. Brain 124:2448-2458.

    Yang H, Fan S, Song D, Wang Z, Ma S, Li S, Li X, Xu M, Xu M, Wang X (2013) Long-term streptozotocin-induced diabetes in rats leads to severe damage of brain blood vessels and neurons via enhanced oxidative stress. Mol Med Rep 7:431-440.

    Zhang XY, Liu JH, Cui Y, Tang P (2008) Electrophysiological examination of peripheral nerve injury and its significance in forensic medicine. Fa Yi Xue Za Zhi 24:280-283.

    Copyedited by Dawes EA, Maxwell R, Wang J, Qiu Y, Li CH, Song LP, Zhao M

    10.4103/1673-5374.177745 http://www.nrronline.org/

    How to cite this article: Li QR, Wang Z, Zhou W, Fan SR, Ma R, Xue L, Yang L, Li YS, Tan HL, Shao QH, Yang HY (2016) Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway. Neural Regen Res 11(2):345-351.

    Funding: The present study was supported by a grant from the National Natural Science Foundation of China, No. 81060141.

    Accepted: 2015-12-22

    *Correspondence to: Hong-ying Yang, M.D., yyh8657@163.com.

    a级一级毛片免费在线观看| 精品日产1卡2卡| 成人二区视频| 国产日韩欧美在线精品| 大香蕉久久网| 国产午夜精品久久久久久一区二区三区| 在线观看一区二区三区| 97在线视频观看| 亚洲国产精品成人综合色| av女优亚洲男人天堂| 如何舔出高潮| 久久久久久久久中文| 久久久久久久久久成人| 身体一侧抽搐| 亚洲av男天堂| 国产精品精品国产色婷婷| 少妇猛男粗大的猛烈进出视频 | 爱豆传媒免费全集在线观看| 久久精品影院6| 日本免费a在线| 日本一二三区视频观看| 蜜桃久久精品国产亚洲av| 免费一级毛片在线播放高清视频| 黄色配什么色好看| 最好的美女福利视频网| 亚洲欧洲日产国产| 亚洲国产色片| 日韩欧美国产在线观看| 夫妻性生交免费视频一级片| 久久欧美精品欧美久久欧美| 国产精品三级大全| 在现免费观看毛片| 亚洲av电影不卡..在线观看| 国产伦理片在线播放av一区 | 我要搜黄色片| 国产日本99.免费观看| 国产精品永久免费网站| 久久久久久久久久久免费av| 亚洲成av人片在线播放无| 成人鲁丝片一二三区免费| 国产精品久久视频播放| 精品午夜福利在线看| 熟女电影av网| 国产激情偷乱视频一区二区| 青青草视频在线视频观看| 国产爱豆传媒在线观看| 亚洲成av人片在线播放无| 国产一级毛片在线| 成人性生交大片免费视频hd| 男女那种视频在线观看| 插逼视频在线观看| 亚洲综合色惰| 99riav亚洲国产免费| 国产一级毛片在线| 人妻制服诱惑在线中文字幕| 亚洲欧美精品专区久久| 日韩强制内射视频| 能在线免费观看的黄片| 欧美变态另类bdsm刘玥| 午夜福利高清视频| 国产一区二区在线av高清观看| 六月丁香七月| 亚洲不卡免费看| 真实男女啪啪啪动态图| 成人一区二区视频在线观看| 国产午夜精品一二区理论片| 精品少妇黑人巨大在线播放 | 中国美白少妇内射xxxbb| 小蜜桃在线观看免费完整版高清| 欧美人与善性xxx| 久久久欧美国产精品| 欧美变态另类bdsm刘玥| 亚洲最大成人中文| 国产精品久久久久久久电影| 神马国产精品三级电影在线观看| 在线观看一区二区三区| 久久精品影院6| 欧美一区二区国产精品久久精品| 一区二区三区四区激情视频 | 日韩国内少妇激情av| 日日摸夜夜添夜夜添av毛片| 久久欧美精品欧美久久欧美| 少妇裸体淫交视频免费看高清| 99热6这里只有精品| 国产伦精品一区二区三区四那| 身体一侧抽搐| 99九九线精品视频在线观看视频| 亚洲人成网站在线播| 人妻制服诱惑在线中文字幕| 亚洲av男天堂| 久久久久网色| av在线亚洲专区| 只有这里有精品99| 欧美zozozo另类| 中出人妻视频一区二区| 亚洲经典国产精华液单| 丰满的人妻完整版| 99在线视频只有这里精品首页| 国产成人精品一,二区 | 老司机福利观看| 欧美激情国产日韩精品一区| 亚洲欧美成人综合另类久久久 | 久久久国产成人精品二区| 国产精品一二三区在线看| 欧美最黄视频在线播放免费| 尤物成人国产欧美一区二区三区| 午夜福利成人在线免费观看| 国产亚洲av片在线观看秒播厂 | 国产亚洲精品久久久com| 色播亚洲综合网| 国产黄片视频在线免费观看| 亚洲精品国产成人久久av| а√天堂www在线а√下载| 毛片女人毛片| 久久草成人影院| 中文在线观看免费www的网站| 日韩一区二区视频免费看| 国产免费男女视频| 啦啦啦韩国在线观看视频| 欧美成人免费av一区二区三区| 少妇人妻精品综合一区二区 | 欧美bdsm另类| 免费电影在线观看免费观看| 丰满乱子伦码专区| 亚洲无线在线观看| 99九九线精品视频在线观看视频| 日日干狠狠操夜夜爽| 国产亚洲精品久久久com| 在线免费观看不下载黄p国产| 老司机福利观看| 日本三级黄在线观看| 尤物成人国产欧美一区二区三区| 国产激情偷乱视频一区二区| 看免费成人av毛片| 边亲边吃奶的免费视频| 亚洲欧美成人综合另类久久久 | 深夜精品福利| 久久久久久久午夜电影| 国产黄片视频在线免费观看| 亚洲高清免费不卡视频| 国产人妻一区二区三区在| 99久国产av精品| 美女被艹到高潮喷水动态| 老熟妇乱子伦视频在线观看| 日本爱情动作片www.在线观看| 亚洲av熟女| 国产黄色小视频在线观看| 男人和女人高潮做爰伦理| 热99re8久久精品国产| 99久久成人亚洲精品观看| 九九爱精品视频在线观看| 啦啦啦韩国在线观看视频| 神马国产精品三级电影在线观看| 欧美xxxx黑人xx丫x性爽| 亚洲人成网站高清观看| 99国产极品粉嫩在线观看| 亚洲欧美日韩卡通动漫| 精品久久久久久久久久免费视频| 国产午夜精品久久久久久一区二区三区| 久久6这里有精品| 日本三级黄在线观看| 国产午夜福利久久久久久| 成年女人永久免费观看视频| 午夜精品国产一区二区电影 | 最新中文字幕久久久久| 久99久视频精品免费| av在线亚洲专区| 一区福利在线观看| 在线免费十八禁| 中文资源天堂在线| 我的女老师完整版在线观看| 日本撒尿小便嘘嘘汇集6| 看免费成人av毛片| АⅤ资源中文在线天堂| 99热全是精品| 网址你懂的国产日韩在线| 久久久久久久久大av| 天美传媒精品一区二区| 中文字幕人妻熟人妻熟丝袜美| 午夜福利高清视频| 亚洲七黄色美女视频| 中文在线观看免费www的网站| 22中文网久久字幕| 嫩草影院入口| 免费一级毛片在线播放高清视频| 日本黄色视频三级网站网址| 三级经典国产精品| 乱码一卡2卡4卡精品| 亚洲av电影不卡..在线观看| 国产亚洲精品av在线| 国产av麻豆久久久久久久| 婷婷精品国产亚洲av| 2022亚洲国产成人精品| 亚洲av.av天堂| 中国国产av一级| 成年免费大片在线观看| 国产熟女欧美一区二区| 一个人免费在线观看电影| 免费黄网站久久成人精品| 悠悠久久av| 最近中文字幕高清免费大全6| 久久久a久久爽久久v久久| 中文字幕av成人在线电影| 日本爱情动作片www.在线观看| 真实男女啪啪啪动态图| 国产一区二区在线观看日韩| 51国产日韩欧美| 日本熟妇午夜| 99久久中文字幕三级久久日本| 欧美xxxx性猛交bbbb| 成人高潮视频无遮挡免费网站| 色吧在线观看| 久久精品久久久久久久性| av天堂中文字幕网| 国产精品精品国产色婷婷| 高清在线视频一区二区三区 | 日本黄色视频三级网站网址| 成人午夜高清在线视频| 午夜视频国产福利| av国产免费在线观看| 日本欧美国产在线视频| 国语自产精品视频在线第100页| 床上黄色一级片| 欧美成人免费av一区二区三区| 亚洲中文字幕一区二区三区有码在线看| 中国国产av一级| 日韩欧美国产在线观看| 国产一区二区在线观看日韩| 日本撒尿小便嘘嘘汇集6| 欧美区成人在线视频| 欧美性猛交╳xxx乱大交人| 成人鲁丝片一二三区免费| 午夜福利在线观看免费完整高清在 | 午夜精品在线福利| 免费av不卡在线播放| 国产一区二区激情短视频| 中文字幕免费在线视频6| 三级国产精品欧美在线观看| 卡戴珊不雅视频在线播放| 午夜视频国产福利| 波多野结衣高清作品| 又爽又黄无遮挡网站| 婷婷亚洲欧美| 国产成人91sexporn| 国产一区二区亚洲精品在线观看| 老司机影院成人| 内地一区二区视频在线| 国产老妇伦熟女老妇高清| 免费看日本二区| 日韩欧美在线乱码| 午夜福利高清视频| 国产精品精品国产色婷婷| 国产日本99.免费观看| 精品国内亚洲2022精品成人| 欧美三级亚洲精品| 日韩欧美一区二区三区在线观看| 国产黄a三级三级三级人| videossex国产| 老师上课跳d突然被开到最大视频| 国产在线男女| 亚洲精品自拍成人| 亚洲18禁久久av| 国产精品久久视频播放| 别揉我奶头 嗯啊视频| 成年版毛片免费区| 亚洲欧洲国产日韩| 国产黄片视频在线免费观看| 国产精品伦人一区二区| 国产精品乱码一区二三区的特点| 欧美又色又爽又黄视频| 成人漫画全彩无遮挡| 秋霞在线观看毛片| 在线国产一区二区在线| 22中文网久久字幕| 国产蜜桃级精品一区二区三区| 国产黄片美女视频| 亚洲成人中文字幕在线播放| 亚洲av一区综合| 青春草国产在线视频 | 精品熟女少妇av免费看| 97超视频在线观看视频| 99久国产av精品国产电影| 99久久精品一区二区三区| 男女下面进入的视频免费午夜| 国产黄色视频一区二区在线观看 | avwww免费| 51国产日韩欧美| 你懂的网址亚洲精品在线观看 | 精品久久久久久成人av| 91aial.com中文字幕在线观看| 国产淫片久久久久久久久| .国产精品久久| 深爱激情五月婷婷| 久久这里有精品视频免费| 婷婷六月久久综合丁香| 亚洲av电影不卡..在线观看| 亚洲成人中文字幕在线播放| 免费看日本二区| 男人舔奶头视频| 99久国产av精品国产电影| 亚洲av二区三区四区| 18禁在线播放成人免费| 国产在线精品亚洲第一网站| 我的女老师完整版在线观看| 尤物成人国产欧美一区二区三区| 成人国产麻豆网| 干丝袜人妻中文字幕| 22中文网久久字幕| 能在线免费观看的黄片| 国产高潮美女av| 欧美xxxx黑人xx丫x性爽| 天天一区二区日本电影三级| 搡老妇女老女人老熟妇| 欧美日韩国产亚洲二区| 亚洲最大成人av| 欧美最黄视频在线播放免费| 国产亚洲91精品色在线| 亚洲在线观看片| 亚洲av.av天堂| 午夜精品国产一区二区电影 | 亚洲婷婷狠狠爱综合网| 久久这里有精品视频免费| 色综合亚洲欧美另类图片| 成人二区视频| 免费观看a级毛片全部| 韩国av在线不卡| 亚洲成人久久性| 一边摸一边抽搐一进一小说| 欧美不卡视频在线免费观看| 91久久精品国产一区二区成人| 特级一级黄色大片| 亚洲精品国产成人久久av| 一级毛片aaaaaa免费看小| 免费av毛片视频| 亚洲久久久久久中文字幕| 人人妻人人澡欧美一区二区| 韩国av在线不卡| 亚洲电影在线观看av| 亚洲av一区综合| 国产91av在线免费观看| 校园春色视频在线观看| 人体艺术视频欧美日本| 国产一区二区激情短视频| 亚洲av不卡在线观看| 在线a可以看的网站| 日日撸夜夜添| 免费观看的影片在线观看| 午夜久久久久精精品| 亚洲经典国产精华液单| 亚洲熟妇中文字幕五十中出| 亚洲欧美中文字幕日韩二区| 久久精品国产亚洲av涩爱 | 国产精品一区www在线观看| 国产成人一区二区在线| 九九久久精品国产亚洲av麻豆| 性色avwww在线观看| 天堂av国产一区二区熟女人妻| 国产午夜精品久久久久久一区二区三区| 99久久无色码亚洲精品果冻| 国产综合懂色| 99国产极品粉嫩在线观看| 毛片一级片免费看久久久久| 亚洲av成人精品一区久久| 欧美日本亚洲视频在线播放| 亚洲av第一区精品v没综合| 99热这里只有是精品50| 亚洲激情五月婷婷啪啪| 国产黄色小视频在线观看| av在线老鸭窝| 国产精品福利在线免费观看| 99国产精品一区二区蜜桃av| 欧美高清成人免费视频www| 久久久久久久久大av| 国产精品久久电影中文字幕| 美女国产视频在线观看| av在线老鸭窝| 床上黄色一级片| 国产精品电影一区二区三区| 亚洲精品粉嫩美女一区| 欧美高清成人免费视频www| 亚洲最大成人av| 中文资源天堂在线| 最近中文字幕高清免费大全6| 免费看光身美女| 岛国在线免费视频观看| 岛国毛片在线播放| 在线观看午夜福利视频| 国产午夜福利久久久久久| 久久久色成人| 午夜福利高清视频| 国产视频内射| 看非洲黑人一级黄片| 精品久久久久久成人av| 国产私拍福利视频在线观看| 日韩大尺度精品在线看网址| 丰满乱子伦码专区| 久久久久久久久久成人| 卡戴珊不雅视频在线播放| 国产精品1区2区在线观看.| 一边摸一边抽搐一进一小说| 三级国产精品欧美在线观看| 麻豆成人av视频| 校园人妻丝袜中文字幕| 国产精品.久久久| 亚洲五月天丁香| 99视频精品全部免费 在线| 禁无遮挡网站| 国产女主播在线喷水免费视频网站 | eeuss影院久久| 亚洲人成网站在线播| 菩萨蛮人人尽说江南好唐韦庄 | 老女人水多毛片| 精华霜和精华液先用哪个| 一边摸一边抽搐一进一小说| 卡戴珊不雅视频在线播放| 日本在线视频免费播放| 欧美+亚洲+日韩+国产| 日本爱情动作片www.在线观看| 久久人妻av系列| 又粗又爽又猛毛片免费看| 18禁裸乳无遮挡免费网站照片| 直男gayav资源| 波多野结衣高清无吗| 久久韩国三级中文字幕| 麻豆一二三区av精品| 国产精品一及| 三级毛片av免费| 看十八女毛片水多多多| 久久精品影院6| 亚洲av不卡在线观看| 日韩欧美 国产精品| 国产成人影院久久av| 人人妻人人看人人澡| 久久精品夜夜夜夜夜久久蜜豆| 亚洲四区av| 亚洲性久久影院| 亚洲av男天堂| 国产一级毛片在线| 永久网站在线| 性插视频无遮挡在线免费观看| 国产午夜精品一二区理论片| 日韩欧美一区二区三区在线观看| 亚洲av免费高清在线观看| 久久久久久久久久成人| 国产成人精品婷婷| 国产乱人偷精品视频| 男女啪啪激烈高潮av片| 亚洲精品影视一区二区三区av| 99热精品在线国产| 成人av在线播放网站| 国产精品一区二区性色av| 中文字幕精品亚洲无线码一区| 国产一区二区三区av在线 | av免费观看日本| 色尼玛亚洲综合影院| 国产精品人妻久久久影院| 可以在线观看毛片的网站| 久久久久久大精品| 黄色一级大片看看| 日本欧美国产在线视频| 国产av在哪里看| 一卡2卡三卡四卡精品乱码亚洲| 国产精品一及| 久久久久久久久中文| 搡老妇女老女人老熟妇| 三级男女做爰猛烈吃奶摸视频| 国产精华一区二区三区| 日产精品乱码卡一卡2卡三| 国产v大片淫在线免费观看| 最好的美女福利视频网| 夜夜夜夜夜久久久久| 3wmmmm亚洲av在线观看| 国产成人精品一,二区 | 成人亚洲欧美一区二区av| 麻豆国产av国片精品| 亚洲欧美精品专区久久| 一本精品99久久精品77| a级毛片a级免费在线| 欧美激情久久久久久爽电影| 久久久色成人| 国产 一区精品| 国产综合懂色| 最近视频中文字幕2019在线8| 欧美不卡视频在线免费观看| 国产精品嫩草影院av在线观看| 国产三级中文精品| 亚洲久久久久久中文字幕| 国产男人的电影天堂91| 久久久久久久久久成人| 春色校园在线视频观看| 国产三级在线视频| 国产大屁股一区二区在线视频| 色综合站精品国产| 色综合色国产| 亚洲国产色片| 国产一区二区在线观看日韩| 中文字幕久久专区| 精品免费久久久久久久清纯| 亚洲第一区二区三区不卡| 青春草国产在线视频 | 国产单亲对白刺激| av免费在线看不卡| 91精品一卡2卡3卡4卡| 18禁在线无遮挡免费观看视频| 国内少妇人妻偷人精品xxx网站| 99久国产av精品| 国产精品人妻久久久影院| 色5月婷婷丁香| 性色avwww在线观看| 日日啪夜夜撸| 国产乱人偷精品视频| 成人特级av手机在线观看| 欧美不卡视频在线免费观看| 国产精品一区www在线观看| 18禁黄网站禁片免费观看直播| 国产乱人偷精品视频| 九九热线精品视视频播放| 国产午夜精品论理片| 日日干狠狠操夜夜爽| 国产精品1区2区在线观看.| 精品久久久久久久末码| 老熟妇乱子伦视频在线观看| 狠狠狠狠99中文字幕| 波野结衣二区三区在线| 日韩高清综合在线| 亚洲欧美精品自产自拍| 在线免费十八禁| 亚洲av中文av极速乱| 夜夜夜夜夜久久久久| 欧美日韩精品成人综合77777| 亚洲av电影不卡..在线观看| 91麻豆精品激情在线观看国产| 亚洲三级黄色毛片| АⅤ资源中文在线天堂| 日韩成人伦理影院| 国产精品爽爽va在线观看网站| 看黄色毛片网站| 嫩草影院新地址| 精品少妇黑人巨大在线播放 | 国产黄色视频一区二区在线观看 | 91麻豆精品激情在线观看国产| 啦啦啦观看免费观看视频高清| 精品久久久久久久久av| 在线国产一区二区在线| 欧美性猛交╳xxx乱大交人| 国产精品一区二区三区四区免费观看| 毛片一级片免费看久久久久| 日本黄色视频三级网站网址| 亚洲国产色片| 人人妻人人澡欧美一区二区| 91精品国产九色| 日日撸夜夜添| 99精品在免费线老司机午夜| 中国国产av一级| 免费无遮挡裸体视频| 亚洲精品影视一区二区三区av| 亚洲国产精品合色在线| 免费搜索国产男女视频| 在线观看免费视频日本深夜| 亚洲国产精品成人久久小说 | 国产精品一区www在线观看| 亚洲精品久久久久久婷婷小说 | 久久综合国产亚洲精品| 不卡视频在线观看欧美| 久久韩国三级中文字幕| 亚洲人成网站在线播放欧美日韩| 久久久色成人| 亚洲精品久久久久久婷婷小说 | 亚洲最大成人手机在线| 国内少妇人妻偷人精品xxx网站| 日本撒尿小便嘘嘘汇集6| av免费观看日本| 色播亚洲综合网| 小说图片视频综合网站| 一本久久中文字幕| 身体一侧抽搐| a级毛色黄片| 男人舔女人下体高潮全视频| 观看免费一级毛片| 亚洲国产欧美人成| 国产午夜精品论理片| 夜夜爽天天搞| 夜夜看夜夜爽夜夜摸| 午夜爱爱视频在线播放| 2021天堂中文幕一二区在线观| 成熟少妇高潮喷水视频| 久久中文看片网| 看片在线看免费视频| 青春草亚洲视频在线观看| 搞女人的毛片| 能在线免费看毛片的网站| 国产极品精品免费视频能看的| 可以在线观看的亚洲视频| 日韩欧美精品v在线| 精品99又大又爽又粗少妇毛片| 国产私拍福利视频在线观看| 99热这里只有是精品50| 最近视频中文字幕2019在线8| 国产毛片a区久久久久| 国产精华一区二区三区| 神马国产精品三级电影在线观看| 人妻久久中文字幕网| 波多野结衣高清作品| 亚洲性久久影院| 欧美zozozo另类| 人妻夜夜爽99麻豆av| 99热这里只有是精品在线观看| 亚洲成人中文字幕在线播放| 色尼玛亚洲综合影院| 长腿黑丝高跟| 麻豆成人av视频| 在线观看午夜福利视频| 中文字幕av成人在线电影| 中出人妻视频一区二区| 色吧在线观看|